(HealthDay)—Deep learning algorithms, such as convolutional neural networks (CNNs), can automatically and objectively perform image-based Psoriasis Area and Severity Index (PASI) scoring, according to a study published ...
Dec 21, 2021
0
3
Although the most immediately threatening symptoms of COVID-19 are respiratory, neuroscientists are intently studying the pandemic from the perspective of the central nervous system. Clinical research and case reports provide ...
Apr 29, 2020
0
490
A team of researchers at Texas A&M University, Northwestern University, and ImmunoGenesis has discovered a treatment for glioblastoma that has promising implications for the human version of the aggressive cancer form that ...
Aug 27, 2021
0
623
Several drugs already approved by the U.S. Food and Drug Administration (FDA) could potentially be used to alleviate the symptoms of COVID-19, biomedical researchers at Université de Montréal have found.
Dec 17, 2020
0
14
A study analyzing data from the Rhode Island Consortium for Autism Research and Treatment (RI-CART) found that only 3% of individuals diagnosed with autism spectrum disorder reported having fully received clinical genetic ...
May 13, 2020
0
34
Taking vitamin D supplements does not reduce the risk of asthma attacks in children or adults, according to an updated Cochrane Review.
Feb 5, 2023
0
55
Bladder cancer presents a number of challenges when choosing a course of treatment, but researchers at Iowa State University hope their innovative research might help doctors and patients arrive at an optimal treatment plan ...
Dec 7, 2021
0
18
New research published today in Alzheimer's & Dementia, the journal of the Alzheimer's Association could explain why neurons fail to communicate effectively in people with Alzheimer's disease (AD). The study conducted by ...
Jan 25, 2022
0
26
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients—20 out of 24 as of an interim analysis of the phase 1b trial data. The early findings ...
Mar 31, 2019
2
185
In a study carried out in mice at the University of Chicago, researchers found that lasofoxifene outperformed fulvestrant, the current gold-standard drug, in reducing or preventing primary tumor growth. It also was more effective ...
May 13, 2021
0
419
